Top segments and regional performance

Last year, the company generated ‪403.43 B‬ USD, the most of which — ‪336.65 B‬ USD — came from its top-performing segment, North American Pharmaceutical. The greatest contribution came from North America, which accounted for ‪336.65 B‬ USD last year.